Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon CancerUlrike Sack(Charité - Universitätsmedizin Berlin), Ulrike Stein(German Cancer Research Center)JNCI Journal of the National Cancer InstituteJune 17, 201110.1093/jnci/djr190Cited by 211SaveCiteExport RISWatch citationsRelated PapersEpigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression|Oncotarget|2017|55The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis|Oncogene|2021|14